Cite
MLA Citation
M. Al-Bakir et al.. “An Audit of the Use of Cabazitaxel for the Treatment of Metastatic Castrate Resistant Prostate Cancer (mCRPC) Compared with Previous Experience with ECarboF (Epirubicin, Carboplatin and 5-fluorouracil) in a Single Institution.” Clinical oncology, vol. 28, no. 5, 2016, pp. e12–. http://access.bl.uk/ark:/81055/vdc_100031428895.0x000007